New Clinical Guidelines for Postmastectomy Radiation Therapy in Breast Cancer Patients
New guidelines published in 2025 outline evidence-based recommendations for postmastectomy radiation therapy in breast cancer treatment, emphasizing personalized approaches and advanced planning techniques.
Recently published in the journal Practical Radiation Oncology on September 16, 2025, a comprehensive set of clinical practice guidelines has been established for the application of postmastectomy radiation therapy (PMRT). Developed by a multidisciplinary task force led by Dr. Rachel B. Jimenez from Massachusetts General Hospital, these recommendations aim to optimize treatment strategies for breast cancer patients undergoing mastectomy.
The guidelines emphasize that PMRT is highly indicated for patients with node-positive breast cancer, and may also benefit some patients with node-negative disease following upfront mastectomy. For those with locally advanced disease or residual nodal disease after neoadjuvant systemic therapy, PMRT is recommended to reduce the risk of recurrence. Additionally, for patients with clinical tumor stages T1-3N1 or T3N0 who have negative nodes after systemic therapy, PMRT is conditionally advised.
Treatment planning advocates for the use of advanced imaging, specifically computed tomography-based volumetric planning with three-dimensional conformal radiotherapy. When goal achievement is not possible with 3D conformal RT, intensity-modulated radiotherapy (IMRT) is recommended to enhance precision. To minimize damage to normal tissues, deep inspiration breath-hold techniques are advised, especially in cases where vital structures are at risk.
In cases involving skin or superficial margins, the use of a tissue-equivalent bolus is recommended to ensure adequate dose delivery; however, routine use of bolus material is not advised across all cases.
The guidelines also underline that the benefits of PMRT must be balanced with individual patient characteristics and personal preferences, underscoring the importance of personalized, evidence-based decision-making. Overall, these guidelines aim to improve clinical outcomes and tailor therapy to each patient’s unique disease profile.
For further details, the guidelines and clinical recommendations can be accessed in the September 2025 issue of Practical Radiation Oncology. These updates support clinicians in making informed choices while advancing breast cancer treatment protocols.
source: https://medicalxpress.com/news/2025-09-guidelines-postmastectomy-therapy.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Video-Assisted Thoracoscopic Surgery Significantly Lowers Mortality in Early-Stage Lung Cancer Patients
Meta-analysis reveals that video-assisted thoracoscopic surgery (VATS) reduces mortality by 21% in early-stage lung cancer patients compared to traditional lobectomy, highlighting its growing role in surgical treatment.
Study Reveals Digital Disparities Impacting Diabetes Care Access
Research highlights significant demographic disparities in access to telemedicine for type 2 diabetes, urging efforts to bridge the digital divide and improve health equity.
Impact of Limited Medicare Drug Coverage on Multiple Sclerosis Outcomes
Narrower Medicare drug coverage is associated with increased relapse rates in multiple sclerosis patients. Broader formularies improve treatment access and health outcomes, highlighting the need for policy changes.
Innovative Molecular Degraders Offer New Hope for Aggressive Breast Cancer Treatment
Scientists have developed innovative molecular degraders that target the 'undruggable' RNA-binding protein HuR, offering promising new treatments for aggressive breast cancer and other diseases.